language_icon
EN
HI

Caplin Point Laboratories Share price

CAPLIPOINT

1841.8

26.80 (1.48%)
NSE
BSE
Last updated on 13 May, 2026 | 15:31 IST
Today's High

1867.00

Today's Low

1815.20

52 Week Low

1500.30

52 Week High

2395.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Caplin Point Laboratories Chart

Caplin Point Laboratories Share Key Metrics

Volume
65257.00
Market Cap
13999.83 CR
LTQ@LTP
1@1841.80
ATP
1843.77
Var Margin
17.88 %
Circuit Range
1452-2178
Delivery %
59.61 %
Value
12.03 CR
ASM/GSM
No
Market Lot
1

Summary

13 May, 2026 | 15:31 को, Caplin Point Laboratories का शेयर प्राइस आज ₹1841.8 पर है, जो दिन के लिए 26.80% की 1.48 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1815.20 और ₹1867.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1500.30 से ₹2395.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Caplin Point Laboratories ने 65257 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹76011696 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹184377 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,184180 रही। यह स्टॉक ₹1452-2178 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹12.03 CR है। दिन के लिए डिलीवरी परसेंटेज 59.61% रही। इसके अतिरिक्त, Caplin Point Laboratories वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Caplin Point Laboratories Fundamentals

View More
P/E Ratio

22.42

P/B Ratio

4.14

Div. Yield

0.33

Sector P/E

67.07

Sector P/B

3.49

Sec. Div. Yield

0.57

Caplin Point Laboratories Resistance and Support

Pivot 1823.8

Resistance

First Resistance

1846

Second Resistance

1877

Third Resistance

1899.2

Support

First Support

1792.8

Second Support

1770.6

Third Support

1739.6

Caplin Point Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

70.56%

Mutual Fund

1.86%

Insurance

0.14%

Foreign Institutional Investors

4.86%

Domestic Institutional Investors

0.11%

Retail

22.47%

Others

0%

Total Promoters
MAR '24
70.62%
JUN '24
70.56%
SEP '24
70.56%
DEC '24
70.56%

Caplin Point Laboratories Corporate Actions

DateAgenda
2026-05-14Audited Results & Interim Dividend
2026-02-05Quarterly Results

Caplin Point Laboratories News

Caplin Point Laboratories Limited

Caplin Point Laboratories will hold a board meeting on May 14, 2026. The agenda includes considering annual financial results for FY26 and the declaration of an interim dividend, if any, along with fixing its record date.
May 07 2026 16:05:00

Caplin Point Laboratories Limited

CAPLIN POINT LABORATORIES LIMITED board will convene on May 14, 2026, to review and approve the audited annual standalone and consolidated financial results for the financial year ending March 2026. Additionally, the board will consider declaring an interim dividend for shareholders.
May 07 2026 16:05:00

Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Declaration Of Interim Dividend, If Any, Approved By The Board.

Caplin Point Laboratories has scheduled a board meeting for May 14, 2026. The agenda includes the consideration and approval of the annual audited financial results for FY2025-26 and the potential declaration of an interim dividend, along with fixing its record date.
May 07 2026 16:05:00

Caplin Point Laboratories Limited

Caplin Point's subsidiary, Caplin Steriles Limited, has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Calcium Gluconate Injection USP. This approval opens access to the US market for a drug with annual sales of approximately $71 million.
May 05 2026 12:05:00

Caplin Point Laboratories Limited

Caplin Point Laboratories filed its Q4 FY26 shareholding pattern. The promoter and promoter group collectively hold 70.57% of total shares, while public shareholding is 29.43%. Mutual funds hold 0.0202% of the company's shares.
Apr 21 2026 14:04:00
Read More

About Caplin Point Laboratories AboutThe

NSE : 3906  
BSE : 524742  
ISIN : INE475E01026  

The Company was incorporated on 16th April 1990 under the Act as a Private Limited Company under the name of CAPLIN POINT LABORATORIES PRIVATE LIMITED. The name of the Company was changed to CAPLIN POINT LABORATORIES LIMITED effective 23rd April 1993. The Company has adopted a new set of Articles on 12th March 1993 as applicable to public limited companies.The Company was incorporated as an extension of a pharmaceutical manufacturing unit started by M/s Triwin Pharmaceuticals the first pharmaceutical venture started by Mr. P C Partheeban (presently the Managing Director) Mr. T Palanisamy and Mr. S Karunakaran in the year 1987 as a partnership firm. In the year 1990 the Company was incorporated by the partners of the aforesaid firm alongwith Mr. B A Ahmed. Soon thereafter Mr. S Jayaraman joined the Board to take charge of production. Recently the Board has been recast with all Directors except Mr.P.C.Partheeban making room for broadbasing the Board. The resigning Directors have taken positions as Senior level Managers in the Company.M/s Triwin Pharmaceuticals was engaged in the business of manufacture of Tablets Liquid orals and Capsules (Non-Antibiotic) and Import Sales of family planning andcertain life saving drugs. The said firm also started theExport of manufactured formulations in the year 1992-93.Even after the incorporation of the Company the firm continued its manufacturing sales and export of Tablets Liquid orals and Capsules (Non-Antibiotic) and business of import sales while the Company started the manufacture of Ointments Oral Powders and Capsules (Antibiotic).The said firm has since been taken over by the Company with effect from 1st September 1993 with the objective of consolidation of the business of the Company into a single larger entity for setting up the Project envisaged. All the assets and liabilities of the firm were taken over at book values as at 31st August 1993. The Company''s turnover in future shall comprise of the sales generated from the manufacturing faculties of the erstwhile firm also. Salient terms of the takeover Agreement executed by the Company with M/s. Triwin Pharmacuticals (''Triwin'') are as follows.a. Transfer and vesting of assets and liabilities of Triwin in the Company All the assets and liabilities of Triwin including itsfactory located at No. 44 Kamakoti Nagar AnnexeValasaravakkam Madras 600 087 on going business basis aretransferred at book values as on 31st August 1993.b. Net consideration for the transfer of assets and liabilities Consideration payable by the Company shall be the net worthof Triwin (excluding good will) estimated at Rs.3162000on the basis of its audited accounts as at 31st August1993.c. Continuance of Business In the post-transfer stage the Company to continue to dothe business then carried on by Triwin (including themanufacturing operation) and Triwin shall suspend all theproduction/sales activities hitherto carried on by them.d. Discharge of Purchase consideration The Company to issue at par its Shares credited as fullypaid-up to the partners of Triwin for an aggregate nominalvalue of Rs. 3162000 (Rupees Thirty One lacs Sixty TwoThousand only) in the proportion of amounts lying to thecredit of the respective capital/current accounts as on 31st August 1993.

Read More

Caplin Point Laboratories Management

NamePosition
G VenkatramGeneral Counsel & Company Secretary, Compliance Officer
C C PaarthipanChairman
View More

Caplin Point Laboratories FAQs

Caplin Point Laboratories शेयर का खरीद मूल्य 1841.8 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Caplin Point Laboratories शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Caplin Point Laboratories शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 22.42 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Caplin Point Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.14 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Caplin Point Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.49 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Caplin Point Laboratories का मार्केट कैप 13999.83 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Caplin Point Laboratories शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2395.00 और 1500.30 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost